180 related articles for article (PubMed ID: 26820992)
1. Rad51c- and Trp53-double-mutant mouse model reveals common features of homologous recombination-deficient breast cancers.
Tumiati M; Munne PM; Edgren H; Eldfors S; Hemmes A; Kuznetsov SG
Oncogene; 2016 Sep; 35(35):4601-10. PubMed ID: 26820992
[TBL] [Abstract][Full Text] [Related]
2. Loss of Rad51c accelerates tumourigenesis in sebaceous glands of Trp53-mutant mice.
Tumiati M; Hemmes A; Uusivirta S; Koopal S; Kankainen M; Lehtonen E; Kuznetsov SG
J Pathol; 2015 Jan; 235(1):136-46. PubMed ID: 25270124
[TBL] [Abstract][Full Text] [Related]
3. Palb2 synergizes with Trp53 to suppress mammary tumor formation in a model of inherited breast cancer.
Bowman-Colin C; Xia B; Bunting S; Klijn C; Drost R; Bouwman P; Fineman L; Chen X; Culhane AC; Cai H; Rodig SJ; Bronson RT; Jonkers J; Nussenzweig A; Kanellopoulou C; Livingston DM
Proc Natl Acad Sci U S A; 2013 May; 110(21):8632-7. PubMed ID: 23657012
[TBL] [Abstract][Full Text] [Related]
4. Loss of Rad51c leads to embryonic lethality and modulation of Trp53-dependent tumorigenesis in mice.
Kuznetsov SG; Haines DC; Martin BK; Sharan SK
Cancer Res; 2009 Feb; 69(3):863-72. PubMed ID: 19155299
[TBL] [Abstract][Full Text] [Related]
5. Somatic loss of BRCA1 and p53 in mice induces mammary tumors with features of human BRCA1-mutated basal-like breast cancer.
Liu X; Holstege H; van der Gulden H; Treur-Mulder M; Zevenhoven J; Velds A; Kerkhoven RM; van Vliet MH; Wessels LF; Peterse JL; Berns A; Jonkers J
Proc Natl Acad Sci U S A; 2007 Jul; 104(29):12111-6. PubMed ID: 17626182
[TBL] [Abstract][Full Text] [Related]
6. Mammary tumors in mice conditionally mutant for Brca1 exhibit gross genomic instability and centrosome amplification yet display a recurring distribution of genomic imbalances that is similar to human breast cancer.
Weaver Z; Montagna C; Xu X; Howard T; Gadina M; Brodie SG; Deng CX; Ried T
Oncogene; 2002 Aug; 21(33):5097-107. PubMed ID: 12140760
[TBL] [Abstract][Full Text] [Related]
7. Whole-exome DNA sequence analysis of Brca2- and Trp53-deficient mouse mammary gland tumours.
Francis JC; Melchor L; Campbell J; Kendrick H; Wei W; Armisen-Garrido J; Assiotis I; Chen L; Kozarewa I; Fenwick K; Swain A; Smalley MJ; Lord CJ; Ashworth A
J Pathol; 2015 Jun; 236(2):186-200. PubMed ID: 25692405
[TBL] [Abstract][Full Text] [Related]
8. Genomic profiling of murine mammary tumors identifies potential personalized drug targets for p53-deficient mammary cancers.
Pfefferle AD; Agrawal YN; Koboldt DC; Kanchi KL; Herschkowitz JI; Mardis ER; Rosen JM; Perou CM
Dis Model Mech; 2016 Jul; 9(7):749-57. PubMed ID: 27149990
[TBL] [Abstract][Full Text] [Related]
9. The acetyltransferase Tip60 contributes to mammary tumorigenesis by modulating DNA repair.
Bassi C; Li YT; Khu K; Mateo F; Baniasadi PS; Elia A; Mason J; Stambolic V; Pujana MA; Mak TW; Gorrini C
Cell Death Differ; 2016 Jul; 23(7):1198-208. PubMed ID: 26915295
[TBL] [Abstract][Full Text] [Related]
10. The Chromatin Remodeling Component Arid1a Is a Suppressor of Spontaneous Mammary Tumors in Mice.
Kartha N; Shen L; Maskin C; Wallace M; Schimenti JC
Genetics; 2016 Aug; 203(4):1601-11. PubMed ID: 27280691
[TBL] [Abstract][Full Text] [Related]
11. Targeted Pten deletion plus p53-R270H mutation in mouse mammary epithelium induces aggressive claudin-low and basal-like breast cancer.
Wang S; Liu JC; Kim D; Datti A; Zacksenhaus E
Breast Cancer Res; 2016 Jan; 18(1):9. PubMed ID: 26781438
[TBL] [Abstract][Full Text] [Related]
12. Combined Tumor Sequencing and Case-Control Analyses of RAD51C in Breast Cancer.
Li N; McInerny S; Zethoven M; Cheasley D; Lim BWX; Rowley SM; Devereux L; Grewal N; Ahmadloo S; Byrne D; Lee JEA; Li J; Fox SB; John T; Antill Y; Gorringe KL; James PA; Campbell IG
J Natl Cancer Inst; 2019 Dec; 111(12):1332-1338. PubMed ID: 30949688
[TBL] [Abstract][Full Text] [Related]
13. Somatic Trp53 mutations differentially drive breast cancer and evolution of metastases.
Zhang Y; Xiong S; Liu B; Pant V; Celii F; Chau G; Elizondo-Fraire AC; Yang P; You MJ; El-Naggar AK; Navin NE; Lozano G
Nat Commun; 2018 Sep; 9(1):3953. PubMed ID: 30262850
[TBL] [Abstract][Full Text] [Related]
14. Establishment and Characterization of a Brca1
Hámori L; Kudlik G; Szebényi K; Kucsma N; Szeder B; Póti Á; Uher F; Várady G; Szüts D; Tóvári J; Füredi A; Szakács G
Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32053991
[TBL] [Abstract][Full Text] [Related]
15. Somatic structural rearrangements in genetically engineered mouse mammary tumors.
Varela I; Klijn C; Stephens PJ; Mudie LJ; Stebbings L; Galappaththige D; van der Gulden H; Schut E; Klarenbeek S; Campbell PJ; Wessels LF; Stratton MR; Jonkers J; Futreal PA; Adams DJ
Genome Biol; 2010; 11(10):R100. PubMed ID: 20942901
[TBL] [Abstract][Full Text] [Related]
16. Homologous recombination-deficient mutation cluster in tumor suppressor
Prakash R; Rawal Y; Sullivan MR; Grundy MK; Bret H; Mihalevic MJ; Rein HL; Baird JM; Darrah K; Zhang F; Wang R; Traina TA; Radke MR; Kaufmann SH; Swisher EM; Guérois R; Modesti M; Sung P; Jasin M; Bernstein KA
Proc Natl Acad Sci U S A; 2022 Sep; 119(38):e2202727119. PubMed ID: 36099300
[TBL] [Abstract][Full Text] [Related]
17. Spontaneous homologous recombination is decreased in Rad51C-deficient hamster cells.
Drexler GA; Rogge S; Beisker W; Eckardt-Schupp F; Zdzienicka MZ; Fritz E
DNA Repair (Amst); 2004 Oct; 3(10):1335-43. PubMed ID: 15336628
[TBL] [Abstract][Full Text] [Related]
18. Frequent met oncogene amplification in a Brca1/Trp53 mouse model of mammary tumorigenesis.
Smolen GA; Muir B; Mohapatra G; Barmettler A; Kim WJ; Rivera MN; Haserlat SM; Okimoto RA; Kwak E; Dahiya S; Garber JE; Bell DW; Sgroi DC; Chin L; Deng CX; Haber DA
Cancer Res; 2006 Apr; 66(7):3452-5. PubMed ID: 16585167
[TBL] [Abstract][Full Text] [Related]
19. RAD51C deletion screening identifies a recurrent gross deletion in breast cancer and ovarian cancer families.
Schnurbein G; Hauke J; Wappenschmidt B; Weber-Lassalle N; Engert S; Hellebrand H; Garbes L; Becker A; Neidhardt G; Rhiem K; Meindl A; Schmutzler RK; Hahnen E
Breast Cancer Res; 2013 Dec; 15(6):R120. PubMed ID: 24359560
[TBL] [Abstract][Full Text] [Related]
20. Clinical and biological significance of RAD51 expression in breast cancer: a key DNA damage response protein.
Alshareeda AT; Negm OH; Aleskandarany MA; Green AR; Nolan C; TigHhe PJ; Madhusudan S; Ellis IO; Rakha EA
Breast Cancer Res Treat; 2016 Aug; 159(1):41-53. PubMed ID: 27464795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
